Annual Shareholders Equity
$17.00 M
-$19.23 M-53.08%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual stockholders equity is $17.00 million, with the most recent change of -$19.23 million (-53.08%) on December 31, 2023.
- During the last 3 years, CMMB annual shareholders equity has risen by +$6.20 million (+57.35%).
- CMMB annual shareholders equity is now -72.35% below its all-time high of $61.47 million, reached on December 31, 2021.
Performance
CMMB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$16.32 M
+$6.33 M+63.43%
September 1, 2024
Summary
- As of February 8, 2025, CMMB quarterly stockholders equity is $16.32 million, with the most recent change of +$6.33 million (+63.43%) on September 1, 2024.
- Over the past year, CMMB quarterly shareholders equity has increased by +$6.33 million (+63.43%).
- CMMB quarterly shareholders equity is now -76.02% below its all-time high of $68.04 million, reached on June 30, 2021.
Performance
CMMB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CMMB Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.1% | +63.4% |
| 3 y3 years | +57.4% | +63.4% |
| 5 y5 years | +57.4% | +63.4% |
CMMB Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.3% | at low | -73.5% | +63.4% |
| 5 y | 5-year | -72.3% | +57.4% | -76.0% | +63.4% |
| alltime | all time | -72.3% | +57.4% | -76.0% | +63.4% |
Chemomab Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.32 M(+63.4%) |
| Jun 2024 | - | $9.98 M(-25.1%) |
| Mar 2024 | - | $13.33 M(-21.6%) |
| Dec 2023 | $17.00 M(-53.1%) | $17.00 M(-22.7%) |
| Jun 2023 | - | $21.99 M(-21.3%) |
| Mar 2023 | - | $27.95 M(-22.8%) |
| Dec 2022 | $36.22 M | $36.22 M(-18.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $44.62 M(-13.9%) |
| Jun 2022 | - | $51.84 M(-9.4%) |
| Mar 2022 | - | $57.24 M(-6.9%) |
| Dec 2021 | $61.47 M(+469.0%) | $61.47 M(-6.2%) |
| Sep 2021 | - | $65.51 M(-3.7%) |
| Jun 2021 | - | $68.04 M(+23.3%) |
| Mar 2021 | - | $55.16 M(+410.7%) |
| Dec 2020 | $10.80 M | $10.80 M |
FAQ
- What is Chemomab Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual shareholders equity year-on-year change?
- What is Chemomab Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly shareholders equity year-on-year change?
What is Chemomab Therapeutics annual stockholders equity?
The current annual shareholders equity of CMMB is $17.00 M
What is the all time high annual shareholders equity for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual stockholders equity is $61.47 M
What is Chemomab Therapeutics annual shareholders equity year-on-year change?
Over the past year, CMMB annual stockholders equity has changed by -$19.23 M (-53.08%)
What is Chemomab Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CMMB is $16.32 M
What is the all time high quarterly shareholders equity for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly stockholders equity is $68.04 M
What is Chemomab Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CMMB quarterly stockholders equity has changed by +$6.33 M (+63.43%)